Dr David Wayne Koles, OD in Altus Afb, OK - Optometrist

Dr David Wayne Koles, OD is a Optometrist based in Altus Afb, Oklahoma. Dr David Wayne Koles is licensed to practice in Indiana (license number 18002910A) and his current practice location is 301 N 1st St Bldg 46, Altus Afb, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (580) 481-5239.

NPI number for Dr David Wayne Koles is 1356324412 and his current mailing address is 301 N 1st St Bldg 46, Altus, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1356324412.

Contact Information

	Dr David Wayne Koles, OD
	301 N 1st St Bldg 46, Altus Afb, OK 73523-5004
	(580) 481-5239
	Not Available

Healthcare Provider's Profile

Full Name	Dr David Wayne Koles
Gender	Male
Speciality	Optometrist
Location	301 N 1st St Bldg 46, Altus Afb, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1356324412
Provider Enumeration Date: 11/22/2005
Last Update Date: 08/23/2022

Medical Identifiers

Medical identifiers for Dr David Wayne Koles such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356324412	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	18002910A (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David Wayne Koles is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David Wayne Koles, OD 301 N 1st St Bldg 46, Altus, OK 73523-5004 Ph: (580) 481-5239	Dr David Wayne Koles, OD 301 N 1st St Bldg 46, Altus Afb, OK 73523-5004 Ph: (580) 481-5239

News Archive

Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome

Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.

SORT1 pathway holds promise as new target for therapeutic intervention for LDL cholesterol reduction

The true power of genomic research lies in its ability to help scientists understand biological processes, particularly those that - when altered - can lead to disease. This power is demonstrated dramatically in a pair of papers published today in the journal Nature. In the first, a global team of researchers describes 95 different variations across the genome that contribute in different degrees to alterations in blood cholesterol and triglyceride levels in multiple human populations. In the second report, close examination of just one of these common variants not only reveals the involvement of an unexpected genetic pathway in lipid metabolism but also provides a blueprint for using genomic findings to unravel biological connections between lipid levels and coronary heart disease.

TearLab receives patent for non-invasive tear collection platform

TearLab Corporation today announced that it has been granted U.S. Patent No. 7,810,380, entitled "Systems and methods for collecting tear film and measuring tear film osmolarity." This patent provides the company with broad and blocking intellectual property regarding the measurement of genetic and protein biomarkers within the tear film.

Anxiety linked to severe quality-of-life impairment in postmenopausal women

Whether anxiety increases common menopause symptoms such as hot flashes and sleep disruption or whether these symptoms cause increased anxiety remains an ongoing debate.

Dr David Wayne Koles, OD - Optometrist in Altus Afb, OK